Satisfaction and Preferences for Infusion Therapies in Advanced Parkinson's Disease-Patient Perspective.

ABSTRACT: Background and Objectives: The rapid growth of the number of advanced Parkinson's disease (PD) patients has caused a significant increase in the use of device-aided therapies (DATs), including levodopa-carbidopa intestinal gel (LCIG) and continuous subcutaneous apomorphine infusion (CSAI). The objective of this study was to evaluate patients' satisfaction and the factors influencing preferences for CSAI and LCIG. Materials and Methods: The research focused on individuals diagnosed with advanced PD undergoing DAT at the Neurology Department of the University Hospital in Katowice. A telephone survey conducted between June and July 2024 evaluated the experiences of patients with LCIG and CSAI. The Parkinson's Disease Questionnaire (PDQ-8) and the Stress Scale for Family Caregive

SUBMITTER: Wegrzynek-Gallina J 

PROVIDER: S-EPMC11766721 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature